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Abstract
Background: Explaining policy change is one of the central tasks of contemporary policy analysis. In this article,
we examine the changes in infection control policies for multi-drug resistant tuberculosis (MDR-TB) in South Africa
from the time the country made the transition to democracy in 1994, until 2015. We focus on MDR-TB infection
control and refer to decentralised management as a form of infection control. Using Kingdon’s theoretical framework of
policy streams, we explore the temporal ordering of policy framework changes. We also consider the role of research in
motivating policy changes.
Methods: Policy documents addressing MDR-TB in South Africa over the period 1994 to 2014 were extracted. Literature on
MDR-TB infection control in South Africa was extracted from PubMed using key search terms. The documents were analysed
to identify the changes that occurred and the factors driving them.
Results: During the period under study, five different policy frameworks were implemented. The policies were meant
to address the overwhelming challenge of MDR-TB in South Africa, contextualised by high prevalence of HIV
infection, that threatened to undermine public health programmes and the success of antiretroviral therapy rollouts.
Policy changes in MDR-TB infection control were supported by research evidence and driven by the high incidence
and complexity of the disease, increasing levels of dissatisfaction among patients, challenges of physical, human and
financial resources in public hospitals, and the ideologies of the political leadership. Activists and people living with HIV
played an important role in highlighting the importance of MDR-TB as well as exerting pressure on policymakers, while
the mass media drew public attention to infection control as both a cause of and a solution to MDR-TB.
Conclusion: The critical factors for policy change for infection control of MDR-TB in South Africa were rooted in the
socioeconomic and political environment, were supported by extensive research, and can be framed using Kingdon’s
policy streams approach as an interplay of the problem of the disease, political forces that prevailed and alternative
proposals.
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Background
Multidrug-resistant tuberculosis (MDR-TB) is a major
health problem affecting hundreds of thousands of
people annually worldwide [1, 2]. Globally, the incidence
of MDR-TB is increasing, with 480,000 new cases of
MDR-TB and an estimated 190,000 TB-related deaths in
2014 [3]. South Africa is one of 22 high-burden coun-
tries that account for the majority of incident MDR-TB
cases [1] and has the second-largest number of diag-
nosed MDR-TB cases [4]. It is estimated that approxi-
mately 1.8% of new TB cases and 6.7% of previously
treated TB cases in South Africa are MDR [4, 5]. Ac-
cording to a report published by the Department of
Health [6], approximately 450,000 new cases of TB
occurred in South Africa in 2013, including more than
26,000 cases of MDR-TB. This is burdensome as MDR-
TB is extremely expensive to treat, requiring ZAR
25,000–30,000 per patient for the drugs alone as
opposed to less than ZAR 200 for a new patient with or-
dinary TB [7]. The MDR-TB epidemic in South Africa is
worsened by the HIV epidemic as a result of the im-
paired ability of the immune system to contain TB bacilli
and inadequate airborne infection prevention and
control (IPC) measures [8–11]. The high prevalence of
MDR-TB in South Africa underscores the importance of
effective infection control and treatment programmes
[12–14]. MDR-TB infection control remains one of the
major cornerstones underpinning TB management pro-
grammes [15, 16].
A 2006 surveillance study of drug-resistant TB in
patients with suspected or diagnosed TB in a rural
resource-limited setting in South Africa with a high
prevalence of HIV found a substantially higher preva-
lence of extensively drug-resistant (XDR)- and MDR-TB
than previously reported [17]. The study raised concerns
about the probability of nosocomial transmission of
XDR-TB for two reasons. First, the majority (55%) of pa-
tients had not previously received TB treatment, and a
further 30% had previous outcomes of cured or com-
pleted treatment. Genotyping showed that their strains
were similar, and there was a possibility that transmis-
sion of strains occurred amongst these individuals.
Second, two-thirds of the XDR-TB patients had been
hospitalised at the same district hospital in the 2 years
prior to their diagnosis. The possibility of nosocomial
transmission of TB triggered responses to minimise the
transmission of TB through IPC measures.
Against this background, this paper focuses on the
policy perspectives on the accommodation of MDR-
TB patients and measures for infection control in
South Africa. Several studies have addressed MDR-
TB IPC in South Africa. Notably, Farley et al. [13]
evaluated national infection control strategies, and
provided an overview of IPC measures, but did not
cover policy aspects. The results of their study re-
vealed that IPC measures were generally poorly
implemented in the majority MDR-TB hospitals. To
our knowledge, the IPC policy framework and its im-
plications for MDR-TB have not been not addressed in
the literature.
The incorporation of IPC practices may interrupt the
transmission of TB in healthcare facilities. The WHO
and the Centres for Disease Control and Prevention
have produced IPC guidelines for airborne infectious
diseases such as TB. These guidelines have been adapted
to address resource-limited settings [18, 19]. All of these
proposed guidelines present a hierarchy of control mea-
sures, which are:
1. Administrative control measures to prevent the
generation of and/or exposure to droplet nuclei,
thereby reducing exposure to the bacteria. These
include promptly identifying people with TB symptoms
(triage), separating infectious patients, controlling the
spread of pathogens (cough etiquette and respiratory
hygiene) and minimising time spent in healthcare
facilities.
2. Environmental control measures for high-risk areas,
which either remove the bacteria from the air or re-
duce the concentration of bacteria in the air.
3. Personal protective equipment used by exposed
individuals to protect themselves from inhaling
contaminated air, e.g. the wearing of respirators.
IPC measures are especially important for the manage-
ment of MDR-TB given the challenges associated with
its diagnosis and treatment [20, 21]. They are designed
to protect not only patients, but also those who work in
healthcare settings as they are at higher risk of becoming
infected with MDR-TB [22]. The risks of MDR-TB
transmission in healthcare and congregate settings
underline the urgent need to refocus attention on
IPC measures [23–25].
In order to systematically assess the evolution of policy
on IPC measures and its significance for MDR-TB in
South Africa, we used Kingdon’s theory of policy streams
[26] to examine the factors driving policy change. King-
don’s framework is suitable for our analysis as it allows a
differentiated examination of how certain ideas enter
government agendas and influence policy change. We
also consider the role of research evidence in driving
policy change. We focus on the period from 2000, when
the first policy on MDR-TB was introduced in South
Africa to when the latest one was introduced in 2013.
According to Sabatier and Jenkins-Smith [27], policy
change needs to be observed over a decade or more for
analysis of how policy shapes the agenda and learning
takes place.
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Theoretical framework: Kingdon’s policy streams approach
Kingdon’s policy streams approach assumes continual
policy change. All the elements of the policymaking
process shift and change, and policy outcomes arise
from the continual interplay [26]. In explaining the
process of policy change, Kingdon distinguishes three
streams, namely problem recognition, policy proposals
and politics. Although these streams work largely inde-
pendently of each other, they come together at certain
critical points, at which the greatest policy change is
most likely to happen.
In the stream of problem recognition, the central
question is why governments pay attention to some
problems and not others. Problems enter the agenda for
policy change for various reasons. Often, problems tend
to come to the attention of government decision-makers
not through a given political pressure, but because
certain relatively symbolic indicators simply show that a
problem exists. Governments tend to monitor the per-
formance of systems through standard indicators, often
numerical, such as deaths, costs and disease rates.
Sudden shifts in the indicators or performance contrary
to expectations attract attention and demand policy
changes [28]. However, problems are not self-evident
from indicators. Instead, a focusing event like a crisis,
disaster or personal experience or powerful symbol
might draw attention to a problem. However, such
events have only transient effects unless accompanied by
a firmer indication of a problem, by a pre-existing
perception, or by a combination with other similar
events. Feedback given on a particular problem can
set the impetus for policy change; such feedback may
include programmes that are not working as planned
and consequences of programme enactment.
In the stream of policy proposals, a policy community
of specialists, including bureaucrats, people in planning,
evaluation and budgeting, academics, interest groups
and researchers, constantly generate proposals. Their
ideas bubble around in the policy communities in what
is termed a ‘policy primeval soup’ [26]. The development
of proposals must be performed long before the oppor-
tunity for actual adoption presents itself [28]. The ideas
and proposals are subject to a selection process, with
some being taken into consideration, while others are
discarded. Kingdon identifies three criteria that support
the placement of policy proposals on a government’s
short list, namely they have to be technically feasible,
not too expensive, and acceptable to the public. In
addition, the values held by the public can constrain the
choices that are made in specialised communities.
For Kingdon’s third stream on politics, the political
changes in the administration, partisan or ideological
composition of parliament, and interest group pressure,
are central factors influencing policy agenda setting and
subsequent policy changes. People in and around
government sense a national mood, the climate in the
country, changes in public opinion and broad social
movements. It is when a large number of people in the
country are thinking along certain common lines that
policy agendas and outcomes are bound to change. In
addition, organised political forces in the form of interest
group pressure and political mobilisation provide a
powerful force for policy change.
Certain conditions favour agenda change leading to
policy evolution. According to Kingdon [26], joining the
streams requires policy entrepreneurs who are more or
less constantly at work on pointing attention to particu-
lar problems or policies. However, their likelihood of
influencing the policy agenda is enhanced by a policy
window, which can open either because of change in the
political stream (e.g. an administration change) or the
prevailing mood among the public. Politicians decide to
undertake some sort of initiative on a particular subject
and cast about for ideas to mobilise support for their
proposals and capitalise on the prevailing national mood.
Putting themselves in the market for proposals creates a
window for advocates, and many alternatives are then
advanced by their sponsors. In some cases, policy change
may occur in situations where both the problems and
their solutions may not have changed at all. Instead, the
availability of an alternative that somehow responds to a
new political situation can change the policy agenda.
Methods
The study is based on a review of relevant literature and
an analysis of policy documents on MDR-TB infection
control in South Africa. Policy documents were ex-
tracted for the period 1994 to 2014, with a focus on
infection control policies and not on treatment of MDR-
TB. Five policy documents were identified on the basis
that they addressed MDR-TB. To complement the policy
documents, literature on TB infection control and
MDR-TB in South Africa was reviewed. The literature
search comprised a 20-year review of PubMed (1994–
2014), but commonly cited and highly regarded new and
older publications were not excluded. We searched fo-
cusing on “multidrug-resistant tuberculosis”, “MDR-TB”,
“infection control” and “South Africa” on PubMed using
the search terms:
(((“tuberculosis, multidrug-resistant”[MeSH Terms] OR
(“tuberculosis”[All Fields] AND “multidrug-resistant”[All
Fields]) OR “multidrug-resistant tuberculosis”[All Fields]
OR (“multi”[All Fields] AND “drug”[All Fields] AND
“resistant”[All Fields] AND “tuberculosis”[All Fields]) OR
“multi drug resistant tuberculosis”[All Fields]) OR
((“microb drug resist”[Journal] OR “MDR”[All Fields])
AND TB[All Fields])) AND ((“infection control”[MeSH
Terms] OR (“infection”[All Fields] AND “control”[All
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Fields]) OR “infection control”[All Fields]) AND (“weights
and measures”[MeSH Terms] OR (“weights”[All Fields]
AND “measures”[All Fields]) OR “weights and measure-
s”[All Fields] OR “measures”[All Fields]))) AND (“South
Africa”[MeSH Terms] OR (“South”[All Fields] AND
“Africa”[All Fields]) OR “South Africa”[All Fields]).
The search yielded 28 results that were evaluated for
relevance to the study. The policy documents and litera-
ture on MDR-TB and infection control were analysed
thematically to identify the changes that occurred and
the factors driving them. We also searched the reference
lists of articles identified by the search strategy and se-
lected the ones regarded as relevant. Grey literature in
the form of reports, working papers, government docu-
ments, white papers and evaluations was used to inform
the study.
Results
Policy changes on infection control in South Africa
The National Department of Health in South Africa
introduced a policy framework on the management of
MDR-TB in 1999 [29]. The policy framework empha-
sised prevention as the key to effective control of MDR-
TB, particularly first-line TB treatment as prevention, in
order to reduce the risk of first episodes of active TB
occurring or recurring in people either exposed to infec-
tion or with latent TB. One of the strategies involved
hospitalisation of patients for several months until three
consecutive monthly sputa were culture negative. The
policy stipulated the provision of special and well-
ventilated wards in existing hospitals as a cost-effective
way of managing the spread of MDR strains. If there
was no negative pressure ward, MDR-TB patients were
to be treated in wards with the doors closed and the
windows open. In addition, sputum collection was to
take place in the open air and on the sunny side of the
ward. A special glass roofed veranda, open to the outside
was to be built for this purpose. Inside the ward, it was
mandatory for ward staff to wear particulate respirator
masks impermeable to droplet nuclei. Patients were to
wear ordinary masks to prevent an explosive spread.
Other environmental requirements included installation
of extraction fans.
As a result of increasing incidence of and deaths due
to MDR-TB, the South African government enacted the
South African National Tuberculosis practical guidelines
in 2004 [30]. The failure to control the spread of MDR-
TB was noted as a serious threat to individual patients
as well as to communities. The policy reiterated the IPC
measures of the previous policy and went further to pro-
vide more guidelines. For example, the need for enough
windows to allow for more ventilation was emphasised;
they were to be opened to the outside and not to other
wards and, where possible, windows were to be on
opposite sides of the room to allow for cross ventilation.
Doors were to be kept open to maximise ventilation if
they did not open to other wards or rooms. In areas
where maximum natural ventilation was not possible,
overhead fans were to be installed to enhance ventila-
tion. Mechanical ventilation was recommended in areas
where there was a high concentration of infectious drop-
lets to promote air entry into the room and extraction
from the room to the outside. Furthermore, the guide-
lines stipulated the need to use exhaust ventilation sys-
tems that allowed for exchange of air in the room as
well as extraction of air to the outside. They made a
provision for negative pressure ventilation, with the
room to be kept at negative pressure to the outside, thus
ensuring that air was drawn into the room and
exhausted directly to the outside. Ultraviolet germicidal
irradiation was suggested as an adjunctive measure. The
implementation of these measures was to be guided by
the assessment of risk as well as the availability of
resources. Despite the additional guidelines, cases of
MDR-TB continued to increase [31].
A policy on the management of drug-resistant TB was
developed in 2010 and incorporated IPC measures for
MDR-TB [32]. The policy provided strategies for IPC
and occupational health services for patients and health-
care workers. It was driven by the notion that the man-
agement of MDR-TB was an evolving strategy, hence the
need for adaption through evidence-based information.
The major highlight of the policy was that the manage-
ment of MDR-TB would be conducted in an environment
with appropriate IPC measures to prevent nosocomial
transmission of drug-resistant TB. In addition, the policy
designated infection control officers and committees with
the responsibility of developing and monitoring infection
control plans on a regular basis to ensure the effectiveness
of the interventions implemented.
In 2011, a policy framework was enacted on decentra-
lised and deinstitutionalised management of MDR-TB
for South Africa [33]. It made radical changes, as it was
clear from previous experience that prolonged admission
of MDR-TB patients in specialised hospitals was not
feasible. It was noted that the number of patients diag-
nosed with MDR-TB exceeded the number of available
beds per province. It was expected that the number of
patients would continue to rise and that would result in
the waiting list growing. For example, of approximately
9070 cases of MDR-TB notified in 2009, fewer than 5000
were started on treatment in the nine provinces of South
Africa. Based on the growing evidence, the policy
emphasised the need for improving the control of MDR-
TB through the decentralisation of services. The policy
provided five levels of care with admissions either into a
central provincial MDR-TB unit or a decentralised unit
with patients being referred to satellite MDR-TB units
Saidi et al. Health Research Policy and Systems  (2017) 15:41 Page 4 of 11
closer to their homes, home-based services or commu-
nity support services as their condition stabilised [34].
The policy stipulated that each province, depending on
need, would have a number of decentralised MDR-TB
units. These units were meant for the initiation and
management of MDR-TB patients in a defined geo-
graphical area, initially as inpatients, but then as outpa-
tients. These units could be whole hospitals or wards or
sections of existing provincial, district or sub-district
level hospitals. Patients diagnosed with MDR-TB who
were smear microscopy positive were to be hospitalised
for a period of 8 weeks or until they became smear nega-
tive on two consecutive tests. The decentralisation
process brought an urgent need for additional and
appropriate infrastructure for MDR-TB. Given the lim-
ited facilities, the policy did not make it mandatory for
MDR-TB patients to be admitted to hospital for the dur-
ation of treatment. Instead, the policy recommended
home IPC measures, stipulating adequate ventilation/
open windows, isolating patients (own bedroom where
possible), promoting cough hygiene and ensuring that
patients used surgical masks during waking hours while
at home or when meeting with others. Patients were to
refrain from close contact with children and maximise
time in an open-air environment.
The policy on decentralisation in the treatment of
MDR-TB was aligned with the WHO recommendation
for National Tuberculosis Control programmes for
health system strengthening, mainly through the process
of transferring service delivery to manageable units at
various levels, including the community [35]. Decentral-
isation of diagnostic and treatment services of MDR-TB
was considered a means to improve access for all pa-
tients, especially for those from low-resource settings
[36]. The policy framework was also driven by evidence
that decentralised MDR-TB facilities provided more
effective IPC measures that took social and family pres-
sures into consideration [33]. A study on the treatment
for MDR-TB at a specialised TB treatment centre in
KwaZulu-Natal revealed delayed initiation of treatment
as a challenge that emanated from centralisation [37].
Prolonged hospitalisation also had socioeconomic im-
pacts as some patients were forced to relinquish work
and home responsibilities. It was noted that a significant
proportion of MDR-TB was due to ongoing transmission
of already resistant strains [33]. As a result, emphasis
was given to the importance of a decentralised care
model in improving efficiency and effectiveness for
MDR-TB patients.
Despite the policy on decentralisation and deinstitu-
tionalisation, many MDR-TB patients were hospitalised
to receive treatment. This invoked the need for IPC
measures in healthcare facilities, particularly given that
much nosocomial transmission was likely due to
undiagnosed and untreated MDR-TB patients [17]. In
2013, an updated policy on drug-resistant TB was pub-
lished with specific guidelines on the management of
MDR-TB. The policy indicated that the management of
patients would be conducted in dedicated MDR-TB
units, in other healthcare facilities and in the community
by trained healthcare workers [38]. The policy stipulated
the need for multidisciplinary clinical management
teams in all MDR-TB hospitals. The teams consisted of
infection control officers and committees who had the
mandate of conducting risk assessments. Suspected, but
unconfirmed, MDR-TB patients were to be isolated in a
well-ventilated side ward in a district hospital, if space
allowed. If at home, they were to be educated about
cough hygiene and IPC measures.
As control of MDR-TB was proving to be difficult in
South Africa, various studies were conducted with the aim
of finding effective ways to prevent the spread of the dis-
ease. The studies informed the evolution of MDR-TB IPC
measures resulting in evidence-based policymaking.
Evidence from research
As early as 2002, just a year before TB was declared an
emergency in South Africa, the WHO estimated that
South Africa had over 14,000 cases of MDR-TB every
year, with the country ranking among the top ten
countries in the world with the highest number of cases
[9, 39]. Various studies revealed that the treatment of
MDR-TB in South Africa was not sufficient unless
backed up by IPC measures [13, 40, 41]. A study by
Ghandi et al. [17] indicated that MDR-TB treatment re-
quired a longer course, is more toxic and is more costly
than first-line treatment of TB, and is not readily avail-
able in resource-limited settings. The challenges posed
by MDR-TB, particularly its transmission in the commu-
nity and healthcare settings, impeded the implementa-
tion of antiretroviral scale-up programmes, which were
aimed at controlling the HIV epidemic, decreasing TB-
related mortality and reducing the incidence of TB and
MDR-TB [17, 41]. Research suggested that nosocomial
transmission and previous hospitalisation were strong
risk factors for MDR- and XDR-TB [8, 17]. A study by
Bamford and Taljaard [42] suggested that the hospitals
could be breeding grounds for MDR-TB. Another study
by Gandhi [43] in Tugela Ferry linked the outbreak of
the epidemic to poor airborne infection control.
The outbreak of drug-resistant TB in 2006 in a rural
hospital in KwaZulu-Natal, where 39% of 185 culture-
confirmed patients had MDR-TB, displayed the severity
of the problem [9]. Basu et al. [44] predicted that, with-
out new interventions such as IPC measures, the pro-
portion of inpatients with any form of MDR-TB would
increase from 51% in 2007 to 78% in 2012. The combin-
ation of a large population of HIV-infected susceptible
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hosts with poor TB treatment success rates, a lack of air-
borne infection control, limited drug-resistance testing,
and an overburdened MDR-TB treatment programme
provided ideal conditions for an MDR-TB epidemic of
unparalleled magnitude [8].
The overwhelming challenge of MDR-TB in South
Africa, contextualised by high prevalence of HIV infec-
tion, threatened to consume public health programmes
and undermine the success of antiretroviral therapy
rollouts [45]. Research by Dheda et al. [46] revealed that
many patients with MDR-TB did not only have poor
treatment outcomes, but also had high-grade resistance
and continued to have positive cultures despite treat-
ment intervention. The problem presented acute ethical
dilemmas on whether or not MDR-TB patients should
be discharged into their communities; the major con-
cerns were whether treatment was to be suspended to
prevent further acquisition of resistance or whether pa-
tients should be isolated from society, to which they
posed a threat. Although discharge of infectious and in-
curable patients back into the community was criticised,
the question that arose was whether there were any
alternatives in resource-poor settings [21]. Such ques-
tions revealed the complexity of the problem of MDR-
TB in South Africa. Andrew et al. [45] found that, in a
sample of 17 patients who developed MDR- or XDR-TB
while being treated for a less resistant form of TB, all
cases were due to exogenous reinfection. The study thus
highlights exogenous reinfection as an important mech-
anism for the development of MDR-TB in patients who
are on TB treatment.
The policy on integrated, home-based treatment was
thus informed by research findings revealing that treat-
ment outcomes for MDR-TB in South Africa were poor
as centralised, in-patient treatment programmes strug-
gled to cope with rising prevalence and HIV co-
infection. There was no evidence that hospitalisation
actually limited community transmission, and it was
likely that most patients had been infectious for several
months before hospitalisation given the delays in diagno-
sis and treatment under routine programme conditions
in South Africa [47]. A 2008–2010 study involving a
sample of 80 MDR-TB patients to assess the model of
decentralised treatment in South Africa revealed that re-
tention rates were high, as only 5% of patients defaulted,
while the preliminary outcomes were favourable, with
77% cured/still on treatment and few having had severe
adverse events (8%) or having died (6%) [48]. The re-
search findings pointed to home-based treatment for
MDR-TB as a good model to expand capacity and
achieve improved outcomes in rural, resource-poor and
high HIV-prevalent settings. Linked to this, the WHO
endorsed the Stop TB Strategy, an approach that was
aimed to reduce the burden of MDR-TB in line with
global targets set for 2015 with emphasis on strengthen-
ing infection control in health services, other congregate
settings and households [49].
As nosocomial infection of MDR-TB continued to in-
crease in healthcare settings, the Council for Scientific
and Industrial Research worked towards developing a
management tool for airborne infection control that
would identify critical control points where the risk of
transmission to patients and staff was particularly high.
The project revealed the need to design and build a pub-
lic interface of health facilities, such as outpatient areas
and casualty wards, according to clinically acceptable
standards in order to provide the essential requirements
for infection control [50]. Consequently, the Council for
Scientific and Industrial Research was designated the
task by the National Department of Health to research
and facilitate the design and construction of new long-
term accommodation units for 400 patients in nine
centres across the country [51]. The project provided an
opportunity to review the existing policy, develop guide-
lines for long-term accommodation of patients with
drug-resistant TB and research, and test and validate the
performance of accommodation units provided through
the project. This culminated in national building regula-
tions and standards for healthcare facilities which
stipulated that, where possible, patients were to be
accommodated in single rooms with en-suite facilities, a
staff zone (nursing station and support rooms) was to be
physically separated from the patients’ infectious zone,
and natural ventilation was to be prioritised over artifi-
cial ventilation in all patient areas to achieve maximum
air changes at all times [52]. The shift from artificial ven-
tilation towards natural ventilation resulted from the
former being limited by engineering constraints and
costs such as the increasing risk of power outages and
continuous escalation in electricity tariffs, while the lat-
ter, despite its reliance on climatic conditions, had bene-
fits such as low cost of installation, operation and
maintenance [50, 52].
Discussion
The policy changes with regard to IPC measures for
drug-resistant TB in South Africa can be explained, in
terms of policy streams theory, as an interplay of the
problem of the disease, the political forces that prevailed
and alternative proposals that were available. In the first
instance, the recognition of MDR-TB as a social and
medical problem in South Africa was the major driving
factor for the policy changes. Indicators in the form of
numbers of MDR-TB cases showed continued growth
and meant an increasing burden of the disease on both
the government and society.
The magnitude of the problem of TB in general and
MDR-TB in particular prompted policy changes on
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infection control as the incidence of MDR-TB continued
to increase. The magnitude of the problem came under
the spotlight when TB was declared a national emer-
gency in 2003 [1] and a national crisis in 2005 [53]. The
declarations served as focusing events, which according
to Kingdon [26], propel issues to the top of the policy
agenda. Despite the enactment of a dedicated MDR-TB
policy in 2000, the incidence and case–fatality rates con-
tinued to increase [49]. This meant that concerted
efforts were needed towards comprehensive and pro-
grammatic management of MDR-TB. The impetus was
towards making changes to the existing policy as it had
failed to yield positive results. According to Weyer [54],
most public health settings lacked adequate and appro-
priate infection-control measures; this was juxtaposed
with an extremely high prevalence of HIV (both in pa-
tients and healthcare workers), which represented a pub-
lic health emergency requiring segregation of infectious
patients, urgent improvements in IPC measures and a
rapid, appropriate response to outbreaks. The need for
policy change was reinforced by the outbreak of XDR-
TB in KwaZulu-Natal from 2005 to 2006, which served
as a serious warning that gains made in the treatment of
TB could be lost if IPC measures for MDR-TB were not
effectively and rapidly addressed [17]. This demanded
radical change in infection control resulting in the 2010
policy framework, which called for decentralisation of
MDR-TB services.
Thus, as a result of the increasing problem of MDR-
TB, policy proposals were generated to change the status
quo. As indicated by Kingdon [28], an increasing chal-
lenge with no immediate solution compels a community
of specialists to formulate proposals to address the situ-
ation. That was the case with MDR-TB in South Africa
as stakeholders, such as the Department of Health, non-
governmental organisations and policymakers, sought to
find alternative policy frameworks in the wake of the in-
creased incidence over the period studied. The challenge
with infection control for MDR-TB revolved around in-
adequate accommodation in public hospitals. It was dif-
ficult to comply with infection control strategies in the
crowded settings of public health facilities in South
Africa. Crowding posed a health hazard to healthcare
workers (nurses and medical care officers). A cross-
sectional descriptive study conducted from June to
September 2009 in 24 hospitals for drug-resistant TB
across South Africa [55], revealed that the greatest fear
of healthcare personnel working in drug-resistant TB
wards was contracting MDR- or XDR-TB and infecting
others. Such fear could negatively impact the provision
of quality patient-centred care. An investigation into the
personal experiences and attitudes of medical doctors
towards TB showed that the majority were concerned by
the lack of infection control strategies at the workplace
[56]. Such findings further amplified the need for im-
proved and effective IPC measures.
Various policy proposals were put forward, but their
feasibility was determined by the availability of re-
sources, particularly in the form of adequate infrastruc-
ture [57, 58]. According to Kingdon [28], not all the
proposals have the propensity to rise to the policy
agenda as some are discarded due to the costs involved
during implementation. In the case of infection control,
priority was given to policy proposals that were technic-
ally feasible, not too expensive and acceptable to the
mass public. Policy proposals that required substantial
resources for implementation took time to be adopted –
it was not until 2010 when the policy on decentralisation
was adopted after financial resources were provided by
the Global Fund [34]. The notion of decentralisation of
health services in general dates back to the publication
for comment on an enabling policy for the development
of a District Health System in South Africa [59], which
emphasised the need for devolving decision-making to
the lowest appropriate level.
The overwhelming number of MDR-TB patients in
South Africa facilitated the policy changes towards
decentralisation and home-based care. The policy frame-
work on decentralised and deinstitutionalised manage-
ment of MDR-TB in South Africa was driven by the lack
of hospital beds and the successful demonstration of
decentralisation in pilot sites [33]. The high incidence of
MDR-TB cases resulted in severe congestion of hospitals
as they failed to cope with the number of patients [8].
The lack of resources in terms of adequate and well-
ventilated MDR-TB wards to admit patients prompted
policy change towards community-based care. On the
other hand, the policy change towards community-based
care was also driven by the dissatisfaction of MDR-TB
patients with the lengthy period of hospitalisation. For
example, patients in Eastern Cape staged a demonstra-
tion in December 2009 demanding free passes to go to
their homes; this act of civil disobedience came after a
group of MDR-TB patients at Jose Pearson Hospital in
Port Elizabeth escaped by cutting through the hospital’s
perimeter fence [60].
It is impossible to separate the transmission of TB
from the spread of HIV in the South African context.
TB is the most common cause of death in AIDS pa-
tients, and the most common opportunistic infection for
HIV-infected patients. The politics concerning the re-
sponse of the South African government in addressing
the HIV/AIDS epidemic filters through in the incidences
of all forms of TB. Karim et al. [9] argue that apartheid
created social, economic and environmental conditions
that were favourable for the transmission of TB. These
include overcrowded informal settlements, the migrant
labour system and a deliberately underdeveloped
Saidi et al. Health Research Policy and Systems  (2017) 15:41 Page 7 of 11
healthcare service for black people. Given the historical
background of disease in the apartheid era, there were
high expectations that the new government would make
a concerted effort towards addressing the disease. How-
ever, there was rapid spread of HIV during 1995–2000,
followed by a phase from 2000 where the AIDS mortal-
ity rates increased, resulting in smaller increases in HIV
prevalence [9, 61].
The fight against HIV/AIDS was already recognised in
the Mandela administration, with the adoption of the
Networking HIV/AIDS Community of South Africa
(NACOSA AIDS) plan, and was prioritised as one of the
African National Congress’s Reconstruction and Develop-
ment programmes [62, 63]. However, it was never given
high profile political support. The Mbeki government’s
stance that HIV does not necessarily cause AIDS, and the
then Minister of Health’s strategy of healthy living to
tackle the HIV/AIDS epidemic, were highly controversial
in South Africa. It was only in 2004 that the first National
Strategic Plan against HIV came into effect, resulting in
antiretroviral therapy being made available to the public.
However, during Mbeki’s administration, progress remained
slow. For example, it is estimated that 330,000 lives could
have been saved if the decision to provide antiretroviral
therapy had been made 3 years earlier [9]. The change in
administration in 2008, followed by the 2009 elections and
a new Minister of Health, resulted in HIV becoming the
top public health priority with a rapid increase in testing
and provision of antiretroviral therapy. For example, the
number of functional antiretroviral therapy clinics in-
creased from 362 in 2008 to 3000 in 2013, while the num-
ber of people receiving antiretroviral therapy increased to
about 2.5 million in late 2013, with a target of 3.1 million
people in 2015 [64].
Civil society and patient organisations played a crucial
role in the policy changes for MDR-TB. The experience
with HIV in South Africa was instructive as strong civil
society action spurred policy changes and raised aware-
ness of entitlements to treatment among those affected
by the pandemic [65]. Increasing discontent over the
failure by the government to control the disease was
triggered by the continuous rise in new cases of the dis-
ease due to poor treatment outcomes. South Africans,
particularly the black majority, became frustrated with
the increasing cases of TB infection and blamed the gov-
ernment for its failure to control the disease [7, 66].
Disappointed by the failure of the South African govern-
ment to control MDR-TB, activist organisations, namely
the Treatment Action Campaign and the TB/HIV Care
Association, marched to Cape Town’s Parliament build-
ings on March 24, 2009. They handed over a petition on
TB, which demanded that the government invest more
time, energy and money in developing strategies to
tackle TB [67]. Such pressure from activists on the
government contributed to the policy changes towards
controlling the spread of MDR-TB.
The South African National Tuberculosis Association
used its network of branches and care groups across
South Africa to influence policy changes in partnership
with other stakeholders. For example, along with patient
organisations, such as the Friends of the Sick Associ-
ation, it provided supportive, preventive and curative
services to TB patients and their families, thereby dem-
onstrating the feasibility of decentralised care [9]. This
was important in promoting shifts in policy, particularly
from centralised to decentralised community-based
treatment of MDR-TB.
The mass media contributed to setting the agenda for
the management of MDR-TB. By drawing and sustaining
public attention on the challenges posed by MDR-TB in
South Africa, the media served as a conduit between the
government and the public, a unifier of diverse view-
points and a national watchdog that reflected and
shaped the public discourse. For example, a study on the
representations of MDR- and XDR-TB in 310 South
African newspapers from February 2004 to July 2009 re-
vealed three main themes, namely patient-centred causes
(32.6%), lack of infection control procedures (18.7%) and
health systems failures, while the solutions to tackling
the disease focused on patient-targeted solutions (38.4%),
improving infection control (12.3%), systems restructuring
(10.6%) and diagnostic and therapeutic options (10%) [57].
What is explicit from the media coverage is the emphasis
on ICP procedures as both a cause of and a solution to
MDR- and XDR-TB. Thus, the media played a role in
problem definition, causal interpretation and policy
recommendation.
International humanitarian medical organisations also
contributed towards policy changes of MDR-TB in South
Africa through advocating for decentralisation of service
delivery. Médecins Sans Frontières conducted pilot stud-
ies in Khayelitsha to pre-test the efficacy of a decentra-
lised model of care in which clinically stable patients
with drug-resistant TB were diagnosed and managed by
clinicians in facilities at a primary healthcare level [68].
The interim outcomes were presented in reports in 2009
[69] and 2011 [70], and provided useful insights into
successes and areas for further improvement. The pilot
program served as a feasibility study and experimental
trial. Following remarkable achievements in the use of
the decentralised model, such as increased case detection,
strengthened patient support, increased treatment initi-
ation rates, decreased time from diagnosis to treatment
initiation, improved IPC measures and more efficacious
treatment regimens, the management and responsibility of
the routine, decentralised drug-resistant TB programme
was handed over to the Department of Health at the end
of 2013 [71]. The potential benefits of a new policy are
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often subject to debate and hard for governments to pre-
dict. The pilot initiative by Médecins Sans Frontières pro-
vided first-hand information and confirmed the benefits of
the model [68], thereby paving way for the adoption and
subsequent implementation of the policy.
Policy changes were also strongly grounded in evi-
dence from research. For example, a pilot study that was
conducted in the Hlabisa sub-district in Kwazulu-Natal
revealed that community-based treatment for MDR-TB
was both feasible and safe in rural South Africa and
could be implemented within the existing TB control
programme in rural areas [47]. The policy on integrated,
home-based treatment was based on empirical evidence
that centralised and in-patient treatment programmes
were not effective in controlling MDR-TB in South
Africa [33]. This was complemented by studies that
showed no evidence to substantiate the claims that hos-
pitalisation of MDR-TB patients reduced transmission of
the disease to the community [47, 72]. Instead, various
studies showed that the hospitalisation of MDR-TB pa-
tients in crowded and resource-limited settings posed
risks for nosocomial transmission [45, 73–75]. A math-
ematical modelling study based on the transmission of
drug-resistant TB in South Africa suggested that a large
proportion of newly transmitted cases could be averted
through a combination of community-based care and
simple mask wearing [44, 76]. A study that was con-
ducted in South Africa to evaluate the use of simple sur-
gical masks on MDR-TB revealed a 56% decreased risk
of TB transmission [77]. Cox et al. [78] assessed a novel
way of improving ventilation for TB infection control in
health facilities by conducting a study in primary care
clinic rooms in Khayelitsha. The study revealed that
natural ventilation can be increased through the use of
wind-driven roof turbines, which are a simple and low
cost technology requiring less maintenance and no elec-
tricity as they are driven by natural forces. Such findings
informed the evolution of MDR-TB infection control
policies as they underscored the importance of imple-
menting effective airborne IPC measures in the fight
against the disease.
Conclusion
The growing incidence of MDR-TB in South Africa pro-
pelled the problem to the top of the policy agenda. The
increase in the incidence of the disease against a back-
ground of growing levels of dissatisfaction among pa-
tients, the shortage of physical, human and financial
resources in public hospitals, and the different ideologies
of the political leadership motivated policy changes. Pre-
vention of MDR-TB was considered a priority for MDR-
TB control, given the need to limit the spread of the
disease and considering the high cost, toxicity and poor
treatment outcomes with available therapies. The changes
inevitably arose due to the mounting pressure that was
exerted by the different stakeholders who felt that the sta-
tus quo was unsustainable. The high incidence of MDR-
TB served as a signal that the health system was failing to
adequately deal with the problem of TB. The need to ad-
dress the challenges in controlling MDR-TB opened policy
windows filled with alternative proposals and resulting in
policy changes. The policy changes were influenced by the
context of the problem of MDR-TB in South Africa. The
factors that drove changes in MDR-TB infection control
policies in South Africa are linked to the context in which
the disease was embedded. We conclude that policy
changes for infection control of MDR-TB in South Africa
were critically influenced from a plethora of different
sources rooted in the socioeconomic and political envir-
onment, and were supported by research evidence. The
policy changes can be framed, using Kingdon’s policy
streams approach, as an interplay of the problem of the
disease, the political forces that prevailed and the alterna-
tive proposals available.
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